ROS1 Targeting With Crizotinib in Advanced E-cadherin Negative, ER Positive Lobular Breast Cancer or Diffuse Gastric Cancer Study (ROLo)

Clinical Trial ID NCT03620643

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03620643

Top papers